Virginia Catalyst Awards Caretaker Medical with Grant to Advance VitalStream Development for Improved Patient Outcomes  

The Virginia Catalyst, also known as the Virginia Biosciences Health Research Corporation (VBHRC), has awarded $3.18 million in grants to four life and bioscience projects in the Commonwealth of Virginia. These grants, which will be met with significant matching funds from partner companies, were awarded through Virginia Catalyst’s Grant Round 16. Through this round of funding, Virginia Catalyst has awarded 65 grants totaling nearly $33 million, resulting in over $50 million in matching funds and an additional $821 million in follow-on funding to date.

The awards range from $200,000 to $800,000, with Caretaker Medical receiving an award of $800,000 for the continued advancement of VitalStream to help reduce patient readmission risk.

“Caretaker Medical is honored to be awarded a 2024 grant from VBHRC Virginia Catalyst in collaboration with our world-class research partners Dr. Afsaneh Doryab and Dr. Casey Cavanagh at UVA and Dr. Peter Beling at Virginia Tech. With this funding, our teams will utilize Caretaker’s FDA-Cleared VitalStream® wearable hemodynamic monitoring platform to build physiological and biobehavioral Artificial Intelligence models that predict patient outcomes and guide personalized medical therapies to reduce hospital readmissions,” stated Jeff Pompeo, President & CEO of Caretaker Medical.

“The Virginia Catalyst commercialization program demonstrates Virginia’s commitment to advancing translational innovation and we are very proud to be part of the Commonwealth’s flourishing Life Sciences ecosystem.”